SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-052492 from Haoxi Health Technology Ltd (HAO)

Haoxi Health Technology Ltd
Date: June 13, 2024 · CIK: 0001954594 · Accession: 0001213900-24-052492

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-280174

Date
June 13, 2024
Author
Haoxi Health Technology Limited
Form
CORRESP
Company
Haoxi Health Technology Ltd

Letter

Haoxi Health Technology Limited

June 13, 2024

Via EDGAR

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

Attention: Robert Shapiro

Doug Jones

Nicholas Nalbantian

Erin Jaskot

Re: Haoxi Health Technology Limited

Registration Statement on Form F-1, as amended

Initially Filed on June 13, 2024

File No. 333-280174

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration Statement become effective at 4:30 p.m., Eastern Time, on June 17, 2024, or as soon thereafter as practicable.

Very truly yours,
Haoxi Health Technology Limited

Show Raw Text
CORRESP
1
filename1.htm

Haoxi Health Technology Limited

June 13, 2024

Via EDGAR

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Attention:
    Robert Shapiro

    Doug Jones

    Nicholas Nalbantian

    Erin Jaskot

    Re:
    Haoxi Health Technology Limited

    Registration Statement on Form F-1, as amended

    Initially Filed on June 13, 2024

    File No. 333-280174

Ladies and Gentlemen:

In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests
that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration
Statement become effective at 4:30 p.m., Eastern Time, on June 17, 2024, or as soon thereafter as practicable.

    Very truly yours,

    Haoxi Health Technology Limited

    By:
    /s/ Fan Zhen

    Name:
    Fan Zhen

    Title:
    Chief Executive Officer, Director